In a study of predominantly pediatric SCD patients (ages four to 31, median = 15) receiving CD3/CD19- or TCRαβ/CD19-depleted grafts, all patients had primary engraftment [62]. Here, CD19 is linked to Schnyder corneal dystrophy.